Franklin Street Advisors Inc Biocryst Pharmaceuticals Inc Transaction History
Franklin Street Advisors Inc
- $1.42 Billion
- Q1 2025
A detailed history of Franklin Street Advisors Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Street Advisors Inc holds 60,000 shares of BCRX stock, worth $536,400. This represents 0.03% of its overall portfolio holdings.
Number of Shares
60,000
Previous 60,000
-0.0%
Holding current value
$536,400
Previous $451,000
0.22%
% of portfolio
0.03%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$194 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$178 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$79.8 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$77.8 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$69.9 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.66B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...